Clinical Trials Browser

Phase NA × Adenocarcinoma × 1 year × Clear all

NCT00102544 2026-04-08

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Phase NA Enrolling by invitation

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

NCT05328505 2026-03-24

MIDAS-Prostate

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms, Recurrence

NCT07489820 2026-03-24

AAPICO

Phase NA Not yet recruiting

Adenocarcinoma

NCT06834204 2026-03-23

ACCESS-PC

Phase NA Not yet recruiting

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT07455422 2026-03-06

Endeavor-2

Phase NA Not yet recruiting

Gastrointestinal

Adenocarcinoma, Barrett Esophagus

NCT07444983 2026-03-03

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07417475 2026-02-18

Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction

Phase NA Completed

Adenocarcinoma, Prostatic Neoplasms

NCT07115914 2026-02-17

PSMA PET for Surveillance After Focal Therapy

Phase NA Recruiting

Adenocarcinoma, Disease, Prostatic Neoplasms

NCT07196488 2026-02-09

Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07391982 2026-02-06

DESTINATION 2

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07344844 2026-01-15

SPAR

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07339943 2026-01-14

MicroUSgFLA

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07129551 2026-01-12

NICE-PSMA

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06145750 2025-11-24

FIRSTLUNG

Phase NA Completed

Adenocarcinoma, Disease, Lung Diseases, Lung Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT01946100 2025-11-20

Treatment of Multifocal Lung Adenocarcinoma

Phase NA Terminated

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma in Situ

NCT06046131 2025-11-17

KP-CARAIBES

Phase NA Recruiting

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT07219303 2025-10-29

DE-CART

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT02415101 2025-09-03

NeoResII

Phase NA Completed

Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT06794073 2025-08-29

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Phase NA Not yet recruiting

Gastrointestinal

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT07098026 2025-08-01

Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Phase NA Recruiting

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT04545957 2025-07-28

JUMP

Phase NA Recruiting

GastrointestinalGenitourinaryHead & Neck

Adenocarcinoma, Head and Neck Neoplasms, Liver Neoplasms, Prostatic Neoplasms

NCT05574647 2025-07-24

IP7-PACIFIC

Phase NA Recruiting

Adenocarcinoma, Neoplasms, Prostatic Diseases, Prostatic Neoplasms